Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;27(7):2332-2341.
doi: 10.1002/chem.202003402. Epub 2020 Nov 30.

π-Extended Diaza[7]helicenes by Hybridization of Naphthalene Diimides and Hexa-peri-hexabenzocoronenes

Affiliations

π-Extended Diaza[7]helicenes by Hybridization of Naphthalene Diimides and Hexa-peri-hexabenzocoronenes

Carolin Dusold et al. Chemistry. .

Abstract

The synthesis of an unprecedented, π-extended hexabenzocorene (HBC)-based diaza[7]helicene is presented. The target compound was synthesized by an ortho-fusion of two naphthalene diimide (NDI) units to a HBC-skeleton. A combination of Diels-Alder and Scholl-type oxidation reactions involving a symmetric di-NDI-tolane precursor were crucial for the very selective formation of the helical superstructure via a hexaphenyl-benzene (HPB) derivative. The formation of the diaza[7]helicene moiety in the final Scholl oxidation is favoured, affording the symmetric π-extended helicene as the major product as a pair of enantiomers. The separation of the enantiomers was successfully accomplished by HPLC involving a chiral stationary phase. The absolute configuration of the enantiomers was assigned by comparison of circular dichroism spectra with quantum mechanical calculations.

Keywords: chirality; helicene; hexabenzocoronene; naphthalene; π-extension.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
General structure of a chiral, π‐extended diaza[7]helicene based on HBC and NDI.
Scheme 1
Scheme 1
Synthetic concept to generate 7‐helical HBC 3.
Scheme 2
Scheme 2
Synthesis of symmetric and asymmetric di‐NDI HPBs 2 and 10. a) PdCl2(PPh3)2, CuI, Et3N, toluene, 80 °C, 18 h, yield 82 %. b) TFA, DCM, RT, 3 h. c) DMF, 140 °C, 18 h, yield 56 %. d) Tetrakis‐(tert‐butyl)tetracyclone, toluene, 220 °C, 24 h, yield 29 % (2) and 30 % (10).
Scheme 3
Scheme 3
Synthesis of the naphthalene imide benzimidazole isomers 5 (orange) and 12 (black) and their 1H NMR and UV/Vis absorption spectra. a) Imidazole, 160 °C, 3 h, yield 36 % (5) and 42 % (12).
Figure 2
Figure 2
Crystal structure of 4‐bromo‐1,2‐naphthaleneimidebenzimidazole (5).
Scheme 4
Scheme 4
Final Scholl‐oxidation of HPB 2 leading to the three possible isomers symmetrical HBC 13, 7‐helical HBC 3, and asymmetrical HBC 14; hydrogen atoms without COSY‐correlation: H1 highlighted in orange a) FeCl3, CH3NO2, DCM, 0 °C, o.n. (overnight), yield 43 %.
Figure 3
Figure 3
Important regions of the 1H‐NMR spectrum of 7‐helical HBC 3.
Figure 4
Figure 4
Comparison of UV/Vis absorption spectra of HPB 2 (blue) and 7‐helical HBC 3 (green).
Figure 5
Figure 5
A) (M)‐ and (P)‐configuration of 7‐helcial HBC 3, tBu groups and swallow tail are omitted for clarity; B) chiral separation of 3 (Chiralpak 1BN‐5, n‐heptane/EtOH/diethylamine (DEA) 70:30:0.1, 4mLmin−1, RT); C) CD spectroscopy measurements of (M)‐3 (black) and (P)‐3 (blue) and the corresponding calculated spectra (sTD‐CAM‐B3LYP/def2‐TZVP with D3: grey, light blue; without D3 red, green).
Figure 6
Figure 6
Geometry‐optimised structures of HBC 3 at B3LYP/def2‐SVP without dispersion correction; hydrogen atoms, tBu groups and swallow tail are omitted for clarity; A) top view with relevant distances between the two NDI arms; B) torsion angles of the inner helix; C) side view with interplanar angle of the inner helix; D) representation of the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO).

Similar articles

Cited by

References

    1. None
    1. Cheung K. Y., Chan C. K., Liu Z., Miao Q., Angew. Chem. Int. Ed. 2017, 56, 9003–9007; - PubMed
    2. Angew. Chem. 2017, 129, 9131–9135; - PubMed
    1. Fernández-García J. M., Evans P. J., Medina Rivero S., Fernández I., García-Fresnadillo D., Perles J., Casado J., Martín N., J. Am. Chem. Soc. 2018, 140, 17188–17196; - PubMed
    1. Ma J., Zhang K., Schellhammer K. S., Fu Y., Komber H., Xu C., Popov A. A., Hennersdorf F., Weigand J. J., Zhou S., Pisula W., Ortmann F., Berger R., Liu J., Feng X., Chem. Sci. 2019, 10, 4025–4031; - PMC - PubMed
    1. Majewski M. A., Stępień M., Angew. Chem. Int. Ed. 2019, 58, 86–116; - PubMed
    2. Angew. Chem. 2019, 131, 90–122;